BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17168568)

  • 1. G-protein-coupled receptor trafficking: understanding the chemical basis of health and disease.
    Ulloa-Aguirre A; Janovick JA; Miranda AL; Conn PM
    ACS Chem Biol; 2006 Nov; 1(10):631-8. PubMed ID: 17168568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.
    Conn PM; Ulloa-Aguirre A; Ito J; Janovick JA
    Pharmacol Rev; 2007 Sep; 59(3):225-50. PubMed ID: 17878512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Effective inefficiency': cellular control of protein trafficking as a mechanism of post-translational regulation.
    Conn PM; Janovick JA; Brothers SP; Knollman PE
    J Endocrinol; 2006 Jul; 190(1):13-6. PubMed ID: 16837606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein folding as posttranslational regulation: evolution of a mechanism for controlled plasma membrane expression of a G protein-coupled receptor.
    Conn PM; Knollman PE; Brothers SP; Janovick JA
    Mol Endocrinol; 2006 Dec; 20(12):3035-41. PubMed ID: 16556733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic rescue of conformationally-defective proteins: implications for the treatment of human disease.
    Ulloa-Aguirre A; Janovick JA; Brothers SP; Conn PM
    Traffic; 2004 Nov; 5(11):821-37. PubMed ID: 15479448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An escort for GPCRs: implications for regulation of receptor density at the cell surface.
    Achour L; Labbé-Jullié C; Scott MG; Marullo S
    Trends Pharmacol Sci; 2008 Oct; 29(10):528-35. PubMed ID: 18760490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific ligands as pharmacological chaperones: The transport of misfolded G-protein coupled receptors to the cell surface.
    Nakamura M; Yasuda D; Hirota N; Shimizu T
    IUBMB Life; 2010 Jun; 62(6):453-9. PubMed ID: 20503438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological chaperone action on G-protein-coupled receptors.
    Bernier V; Bichet DG; Bouvier M
    Curr Opin Pharmacol; 2004 Oct; 4(5):528-33. PubMed ID: 15351360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-associated mutations affect GPR56 protein trafficking and cell surface expression.
    Jin Z; Tietjen I; Bu L; Liu-Yesucevitz L; Gaur SK; Walsh CA; Piao X
    Hum Mol Genet; 2007 Aug; 16(16):1972-85. PubMed ID: 17576745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calnexin regulated gonadotropin-releasing hormone receptor plasma membrane expression.
    Brothers SP; Janovick JA; Conn PM
    J Mol Endocrinol; 2006 Dec; 37(3):479-88. PubMed ID: 17170088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug development and the cellular quality control system.
    Conn PM; Janovick JA
    Trends Pharmacol Sci; 2009 May; 30(5):228-33. PubMed ID: 19307028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specializations of a G-protein-coupled receptor that appear to aid with detection of frequency-modulated signals from its ligand.
    Janovick JA; Brothers SP; Knollman PE; Conn PM
    FASEB J; 2007 Feb; 21(2):384-92. PubMed ID: 17172315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of cell-free-produced human endothelin B receptor reveals transmembrane segment 1 as an essential area for ET-1 binding and homodimer formation.
    Klammt C; Srivastava A; Eifler N; Junge F; Beyermann M; Schwarz D; Michel H; Doetsch V; Bernhard F
    FEBS J; 2007 Jul; 274(13):3257-69. PubMed ID: 17535295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Architectural editing: determining the fate of newly synthesized membrane proteins.
    Klausner RD
    New Biol; 1989 Oct; 1(1):3-8. PubMed ID: 2488271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accessory proteins in the biogenesis of G protein-coupled receptors.
    Bermak JC; Zhou QY
    Mol Interv; 2001 Dec; 1(5):282-7. PubMed ID: 14993367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitously expressed GPCR membrane-trafficking orthologs.
    Lehman CW; Lee JD; Komives CF
    Genomics; 2005 Mar; 85(3):386-91. PubMed ID: 15718105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misrouted cell surface GnRH receptors as a disease aetiology for congenital isolated hypogonadotrophic hypogonadism.
    Ulloa-Aguirre A; Janovick JA; Leaños-Miranda A; Conn PM
    Hum Reprod Update; 2004; 10(2):177-92. PubMed ID: 15073146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological chaperones for misfolded gonadotropin-releasing hormone receptors.
    Conn PM; Ulloa-Aguirre A
    Adv Pharmacol; 2011; 62():109-41. PubMed ID: 21907908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the N-linked glycosylation sites of the human relaxin receptor and effect of glycosylation on receptor function.
    Yan Y; Scott DJ; Wilkinson TN; Ji J; Tregear GW; Bathgate RA
    Biochemistry; 2008 Jul; 47(26):6953-68. PubMed ID: 18533687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of G protein-coupled receptor trafficking by inefficient plasma membrane expression: molecular basis of an evolved strategy.
    Janovick JA; Knollman PE; Brothers SP; Ayala-Yáñez R; Aziz AS; Conn PM
    J Biol Chem; 2006 Mar; 281(13):8417-25. PubMed ID: 16446355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.